Levi Strauss & Co. (LEVI) is now among the bigger bargains in its industry.
Within the last year the price ranged from $16 – 24.5 and there is a wide opportunity to get in. Its next earnings report will be released on Jan 14, 2020.

Eagle Pharmaceuticals, Inc.(EGRX)

move, based on 2 analysts offering 12 month price targets for Eagle Pharmaceuticals in the last 3 months. The average price target is $60.00 with a high forecast of $62.00 and a low forecast of $58.00. The average price target represents a 2.99% increase from the last price of $58.26.

Analysts like Brandon Folkes from Cantor Fitzgerald believe that we could see stock price minimum $58.00.

Another prominent analyst, Randall Stanicky of RBC Capital rates EGRX as a Buy. The rating was made just 3 months ago.

Eagle Pharmaceuticals, Inc.(EGRX) Recent News Reports

On average 2.0 articles are written each week about EGRX but this week 2 articles were written and they were 68% Bullish and 32% Bearish.

Eagle Pharmaceuticals, Inc. Target Levels

The market experts are predicting that EGRX is a Moderate Buy. Some other stocks to consider in this sector are:

null